Mumbai-based Ayurvedic D2C brand Kapiva set to raise over Rs 200 Cr from OrbiMed

According to the reports from Entrackr, domestic D2C ayurvedic nutrition brand Kapiva is in late-stage negotiations to raise more than Rs 200 crore from OrbiMed. This is the company’s first investment round for 2022. “OrbiMed is likely to lead Rs 200- 250 crore worth Series C round across several tranches in Kapiva,” “Existing investors such […]

Read More